IBDEI0WT ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14789,1,3,0)
 ;;=3^Aphasia after non-traumatic SAH
 ;;^UTILITY(U,$J,358.3,14789,1,4,0)
 ;;=4^I69.020
 ;;^UTILITY(U,$J,358.3,14789,2)
 ;;=^5007395
 ;;^UTILITY(U,$J,358.3,14790,0)
 ;;=I69.120^^58^707^3
 ;;^UTILITY(U,$J,358.3,14790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14790,1,3,0)
 ;;=3^Aphasia after non-traumatic ICH
 ;;^UTILITY(U,$J,358.3,14790,1,4,0)
 ;;=4^I69.120
 ;;^UTILITY(U,$J,358.3,14790,2)
 ;;=^5007427
 ;;^UTILITY(U,$J,358.3,14791,0)
 ;;=I69.320^^58^707^2
 ;;^UTILITY(U,$J,358.3,14791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14791,1,3,0)
 ;;=3^Aphasia after cerebral infarction
 ;;^UTILITY(U,$J,358.3,14791,1,4,0)
 ;;=4^I69.320
 ;;^UTILITY(U,$J,358.3,14791,2)
 ;;=^5007491
 ;;^UTILITY(U,$J,358.3,14792,0)
 ;;=I69.091^^58^707^9
 ;;^UTILITY(U,$J,358.3,14792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14792,1,3,0)
 ;;=3^Dysphagia after non-traumatic SAH
 ;;^UTILITY(U,$J,358.3,14792,1,4,0)
 ;;=4^I69.091
 ;;^UTILITY(U,$J,358.3,14792,2)
 ;;=^5007421
 ;;^UTILITY(U,$J,358.3,14793,0)
 ;;=I69.191^^58^707^8
 ;;^UTILITY(U,$J,358.3,14793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14793,1,3,0)
 ;;=3^Dysphagia after non-traumatic ICH
 ;;^UTILITY(U,$J,358.3,14793,1,4,0)
 ;;=4^I69.191
 ;;^UTILITY(U,$J,358.3,14793,2)
 ;;=^5007453
 ;;^UTILITY(U,$J,358.3,14794,0)
 ;;=I69.391^^58^707^7
 ;;^UTILITY(U,$J,358.3,14794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14794,1,3,0)
 ;;=3^Dysphagia after cerebral infaction
 ;;^UTILITY(U,$J,358.3,14794,1,4,0)
 ;;=4^I69.391
 ;;^UTILITY(U,$J,358.3,14794,2)
 ;;=^5007516
 ;;^UTILITY(U,$J,358.3,14795,0)
 ;;=I69.351^^58^707^16
 ;;^UTILITY(U,$J,358.3,14795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14795,1,3,0)
 ;;=3^Hemiplegia after CVA-Rt dominant side
 ;;^UTILITY(U,$J,358.3,14795,1,4,0)
 ;;=4^I69.351
 ;;^UTILITY(U,$J,358.3,14795,2)
 ;;=^5007504
 ;;^UTILITY(U,$J,358.3,14796,0)
 ;;=I69.352^^58^707^14
 ;;^UTILITY(U,$J,358.3,14796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14796,1,3,0)
 ;;=3^Hemiplegia after CVA-Lt dominant side
 ;;^UTILITY(U,$J,358.3,14796,1,4,0)
 ;;=4^I69.352
 ;;^UTILITY(U,$J,358.3,14796,2)
 ;;=^5007505
 ;;^UTILITY(U,$J,358.3,14797,0)
 ;;=I69.353^^58^707^17
 ;;^UTILITY(U,$J,358.3,14797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14797,1,3,0)
 ;;=3^Hemiplegia after CVA-Rt non-dominant side
 ;;^UTILITY(U,$J,358.3,14797,1,4,0)
 ;;=4^I69.353
 ;;^UTILITY(U,$J,358.3,14797,2)
 ;;=^5007506
 ;;^UTILITY(U,$J,358.3,14798,0)
 ;;=I69.354^^58^707^15
 ;;^UTILITY(U,$J,358.3,14798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14798,1,3,0)
 ;;=3^Hemiplegia after CVA-Lt non-dominant side
 ;;^UTILITY(U,$J,358.3,14798,1,4,0)
 ;;=4^I69.354
 ;;^UTILITY(U,$J,358.3,14798,2)
 ;;=^5007507
 ;;^UTILITY(U,$J,358.3,14799,0)
 ;;=I69.331^^58^707^40
 ;;^UTILITY(U,$J,358.3,14799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14799,1,3,0)
 ;;=3^Monoplegia Upper Limb after CVA-Rt Dominant Side
 ;;^UTILITY(U,$J,358.3,14799,1,4,0)
 ;;=4^I69.331
 ;;^UTILITY(U,$J,358.3,14799,2)
 ;;=^5007496
 ;;^UTILITY(U,$J,358.3,14800,0)
 ;;=I69.332^^58^707^38
 ;;^UTILITY(U,$J,358.3,14800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14800,1,3,0)
 ;;=3^Monoplegia Upper Limb after CVA-Lt Dominant Side
 ;;^UTILITY(U,$J,358.3,14800,1,4,0)
 ;;=4^I69.332
 ;;^UTILITY(U,$J,358.3,14800,2)
 ;;=^5007497
 ;;^UTILITY(U,$J,358.3,14801,0)
 ;;=I69.333^^58^707^41
